AIMS: The European Society of Cardiology (ESC) European Observational Research Programme (EORP) Cardiomyopathy Registry is a prospective multinational registry of consecutive patients with cardiomyopathies. The objective of this report is to describe the short-term outcomes of adult patients (≥18 years old). METHODS AND RESULTS: Out of 3208 patients recruited, follow-up data at 1 year were obtained in 2713 patients (84.6%) [1420 with hypertrophic (HCM); 1105 dilated (DCM); 128 arrhythmogenic right ventricular (ARVC); and 60 restrictive (RCM) cardiomyopathies]. Improvement of symptoms (dyspnoea, chest pain, and palpitations) was globally observed over time (P < 0.05 for each). Additional invasive procedures were performed: prophylactic implantation of implantable cardioverter-defibrillator (ICD) (5.2%), pacemaker (1.2%), heart transplant (1.1%), ablation for atrial or ventricular arrhythmia (0.5% and 0.1%). Patients with atrial fibrillation increased from 28.7% to 32.2% of the cohort. Ventricular arrhythmias (VF/ventricular tachycardias) in ICD carriers (primary prevention) at 1 year were more frequent in ARVC, then in DCM, HCM, and RCM (10.3%, 8.2%, 7.5%, and 0%, respectively). Major cardiovascular events (MACE) occurred in 29.3% of RCM, 10.5% of DCM, 5.3% of HCM, and 3.9% of ARVC (P < 0.001). MACE were more frequent in index patients compared to relatives (10.8% vs. 4.4%, P < 0.001), more frequent in East Europe centres (13.1%) and least common in South Europe (5.3%) (P < 0.001). Subtype of cardiomyopathy, geographical region, and proband were predictors of MACE on multivariable analysis. CONCLUSIONS: Despite symptomatic improvement, patients with cardiomyopathies remain prone to major clinical events in the short term. Outcomes were different not only according to cardiomyopathy subtypes but also in relatives vs. index patients, and according to European regions.

2nd Department of Medicine Department of Cardiovascular Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Assistance Publique Hôpitaux de Paris Hôpital Européen Georges Pompidou Cardiology Department Sorbonne Paris Cité INSERM U970 Paris France

Centre for Inherited Cardiovascular Diseases Great Ormond Street Hospital Great Ormond Street London WC1N 3JH UK

Department of Cardiology and Structural Heart Diseases School of Medicine in Katowice Medical University of Silesia Ziolowa Street 45 47 40 635 Katowice Poland

Department of Cardiology Odense University Hospital 5000 Odense C Denmark

Department of Cardiology University of Bologna S Orsola Malpighi Hospital Via Giuseppe Massarenti 9 40138 Bologna Italy

Department of Cardiology Zagazig University Hospital Zagazig Egypt

Division of Cardiology Department of Cardiological Thoracic and Vascular Sciences University of Padova via N Giustiniani 2 35100 Padova Italy

EURObservational Research Programme European Society of Cardiology 2035 Route des colles CS 80179 Biot 06903 Sophia Antipolis Cedex France

Fondazione IRCCS Policlinico San Matteo Viale Camillo Golgi 19 27100 Pavia Italy

GVM Care and Research E S Health Science Foundation Maria Cecilia Hospital Via Corriera 1 48010 Cotignola Italy

Heart Failure Center University of Belgrade School of Medicine Belgrade University Medical Center Koste Todorovica 8 11 000 Belgrade Serbia

Inherited Cardiac Disease Unit Complejo Hospitalario Universitario de A Coruña Calle As Xubias 84 15006 A Coruña Spain

Inherited Cardiac Disease Unit Hospital Clínico Universitario Virgen de la Arrixaca Ctra Murcia Cartagena s n El Palmar 30120 Murcia Spain

Inherited Cardiac Disease Unit Hospital General Universitario Gregorio Marañón 28007 Madrid Spain

Serviço de Cardiologia Hospital Garcia de Orta E P E Av Torrado da Silva 2805 267 Almada Portugal

Sorbonne Université Centre de Référence des Maladies Cardiaques Héréditaires Assistance Publique Hôpitaux de Paris ICAN Inserm UMR1166 Hôpital Pitié Salpêtrière Paris France

University College London and Inherited Cardiac Diseases Unit St Bartholomew's Hospital West Smithfield Paul O'Gorman Building 72 Huntley St London WC1E 6AG UK

Eur Heart J Qual Care Clin Outcomes. 2021 Mar 15;7(2):111-113. doi: 10.1093/ehjqcco/qcab001. PubMed

See more in PubMed

Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P  et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J  2007;29:270–276. PubMed

Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D  et al.; American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation  2006;113:1807–1816. PubMed

Charron P, Elliott PM, Gimeno JR, Caforio ALP, Kaski JP, Tavazzi L  et al.; EORP Cardiomyopathy Registry Investigators. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies. Eur Heart J  2018;39:1784–1793. PubMed

McKenna WJ, Maron BJ, Thiene G.  Classification, epidemiology, and global burden of cardiomyopathies. Circ Res  2017;121:722–730. PubMed

Lund LH, Edwards LB, Dipchand AI, Goldfarb S, Kucheryavaya AY, Levvey BJ  et al.  The registry of the International Society for Heart and Lung Transplantation: thirty-third Adult Heart Transplantation Report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant  2016;35:1158–1169. PubMed

Seferović PM, Polovina M, Bauersachs J, Arad M, Gal TB, Lund LH  et al.  Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail  2019;21:553–576. PubMed

Bagnall RD, Weintraub RG, Ingles J, Duflou J, Yeates L, Lam L  et al.  A prospective study of sudden cardiac death among children and young adults. N Engl J Med  2016;374:2441–2452. PubMed

Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA  et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J  2014;35:2733–2779. PubMed

Elliott P, Charron P, Blanes JR, Tavazzi L, Tendera M, Konté M  et al.; EORP Cardiomyopathy Registry Pilot Investigators. European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology. Eur Heart J  2016;37:164–173. PubMed

Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF  et al.  The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med  2003;348:1647–1655. PubMed

Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC  et al.  The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med  2003;348:1639–1646. PubMed

Wilkinson JD, Westphal JA, Bansal N, Czachor JD, Razoky H, Lipshultz SE.  Lessons learned from the Pediatric Cardiomyopathy Registry (PCMR) study group. Cardiol Young  2015;25:140–153. PubMed

Lannou S, Mansencal N, Couchoud C, Lassalle M, Dubourg O, Stengel B  et al.  The public health burden of cardiomyopathies: insights from a nationwide inpatient study. J Clin Med  2020;9:920. PubMed PMC

Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M  et al.  Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J  2016;37:1850–1858. PubMed

Haugaa KH, Basso C, Badano LP, Bucciarelli-Ducci C, Cardim N, Gaemperli O  et al.; EACVI Scientific Documents Committee, EACVI Board members and external reviewers; EACVI Scientific Documents Committee, EACVI Board members and external reviewers. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging  2017;18:237–253. PubMed PMC

Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H  et al.  Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J  2010;31:806–814. PubMed PMC

Pinamonti B, Dragos AM, Pyxaras SA, Merlo M, Pivetta A, Barbati G  et al.  Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. Eur Heart J  2011;32:1105–1113. PubMed

Corrado D, Wichter T, Link MS, Hauer R, Marchlinski F, Anastasakis A  et al.  Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Eur Heart J  2015;36:3227–3237. PubMed PMC

Elliott PM, Gimeno JR, Thaman R, Shah J, Ward D, Dickie S  et al.  Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart  2005;92:785–791. PubMed PMC

O'Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C  et al.; for the Hypertrophic Cardiomyopathy Outcomes Investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J  2014;35:2010–2020. PubMed

Cadrin-Tourigny J, Bosman LP, Nozza A, Wang W, Tadros R, Bhonsale A  et al.  A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J  2019;40:1850–1858. PubMed PMC

Wolff G, Lin Y, Karathanos A, Brockmeyer M, Wolters S, Nowak B  et al.  Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials. Clin Res Cardiol  2017;106:501–513. PubMed